Alzamend Neuro, Inc.
Developing lithium & vaccine therapies for neurodegenerative & psychiatric disorders.
ALZN | NDAQ
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- United States of America
- Address:
- 480 PEACHTREE ROAD NE, SECOND FLOOR, 30326 ATLANTA
- Website:
- https://alzamend.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Alzamend Neuro, Inc. is a clinical-stage biopharmaceutical company focused on developing novel products for the treatment of neurodegenerative and psychiatric disorders. The company's mission is to develop and market safe and effective treatments for conditions including Alzheimer’s disease, Bipolar Disorder, Major Depressive Disorder (MDD), and Post-Traumatic Stress Disorder (PTSD). Its pipeline consists of two primary therapeutic candidates: AL001, a patented ionic cocrystal technology for delivering lithium, and ALZN002, a patented cell-based therapeutic vaccine intended to help a patient's immune system combat Alzheimer's. Both product candidates are licensed from the University of South Florida Research Foundation.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Alzamend Neuro, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Alzamend Neuro, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Alzamend Neuro, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
